(firstQuint)The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis.

 1.

 Using the response rate and completely response time to compare the efficacy of FK506 versus CTX therapy for the severe FSGS patients.

 2.

 To compare the safety and tolerability of FK506 versus CTX for the severe FSGS patients.

.

 The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis@highlight

This is a prospective,multicentre study to compare the efficacy, safety, tolerability and relapse of FK506 versus CTX in the treatment of severe Focal Segmental Glomerulosclerosis (FSGS).

